23rd Nov 2010 11:53
| |||||||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | Synergy Healthcare | ||||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||||
An acquisition or disposal of voting rights |
Yes | ||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
No | ||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
No | ||||||
An event changing the breakdown of voting rights |
No | ||||||
Other (please specify): | |||||||
3. Full name of person(s) subject to thenotification obligation: iii | Global AEGON Asset Management Group | ||||||
4. Full name of shareholder(s) (if different from 3.):iv | |||||||
5. Date of the transaction and date onwhich the threshold is crossed orreached: v |
19th November 2010 | ||||||
6. Date on which issuer notified: |
23rd November 2010 | ||||||
7. Threshold(s) that is/are crossed orreached: vi, vii |
5-6% | ||||||
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares viii, ix | ||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | ||||||||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
GB0030757263
| 3,256,148
| 3,256,148
| 2,666,425
| 2,666,425
| 681,218
| 4.86%
| 1.24%
| |||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | ||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to
| % of voting rights xix, xx
| |||||||||||
Contract for Difference | n/a | n/a | n/a | n/a | Nominal | Delta | ||||||||||
n/a | n/a | |||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
3,347,643
| 6.10%
| |||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | ||
Global AEGON Asset Management group "AAM" -
AEGON Asset Management Holding BV
AEGON Asset Management UK Holdings Ltd
AEGON Asset Management UK plc
AEGON Investment Management UK ltdAEGON ICVC | ||
Proxy Voting: | ||
10. Name of the proxy holder: | Global AEGON Asset Management Group | |
11. Number of voting rights proxy holder will ceaseto hold: | ||
12. Date on which proxy holder will cease to holdvoting rights: | ||
13. Additional information: | ||
14. Contact name: | Miranda Beacham | |
15. Contact telephone number: | 0131 549 3460 | |
Related Shares:
SYR.L